A Review Of who makes the diabetes drug copyright
In March 2025, the company declared new strategies for just a direct-to-purchaser offering of its Wegovy weight loss drug. The company proven a whole new pharmacy, known as NovoCare, which might charge consumers $499 each month for access to the drug, under 50 percent the expense of the drug as a result of other pharmaceutical distribution networks